The Chief Information Officer of Affidea – a leading pan-European provider of advanced diagnostic imaging, outpatient and cancer services – has told an audience of leading private healthcare companies that artificial intelligence (AI) will revolutionise the way clinicians interact with patients across the continent.
Speaking to a distinguished audience of European clinicians and medical leaders at the 2018 Private Health Forum in Budapest, Milan Glavaski stated that AI has the potential to radically improve interaction between clinician and patient, allowing doctors to spend considerably more time with their patients. As healthcare providers such as Affidea begin introducing new AI and cloud-based technologies, outdated modes of working will be greatly reduced. This will allow clinical teams to spend up to 40% more time each day with their patients, helping to enhance efficiency and confidence in their decision making.
Milan Glavaski talked about Affidea’s ambition to become the premier digital healthcare provider with the most extensive network of centres, powered by artificial intelligence. Affidea, through its 246 centres based in 16 European countries creates and stores standardised data sets in a uniform way, setting a benchmark for best practice across the medical imaging sector.
You might also like: How artificial intelligence spells real change for patients
Affidea is exploring partnerships with companies across the global healthcare and information technology industries to support the development of novel software devices, with the potential to improve medical outcomes for patients across Europe.
Affidea’s CIO also outlined how adopting cloud-based technologies was continuously generating value across the business, by eliminating dependencies on fragmented data sets and hardware obsolescence while improving the security of patients’ data. He highlighted that key areas of growth for Affidea in the coming year would be reached by moving to common IT platforms shared by business units across the continent. He also said that Affidea would become a leading disruptor in the healthcare sector, using cloud-based platforms to go to market quicker with new, unique value proposition to patients and doctors or deploy advanced outcomes such as AI-powered medical devices in its large scale operations.
Speaking at the 2018 Private Health Forum in Budapest, Milan Glavaski said:
“As the leading European provider of advanced diagnostic imaging, outpatient and cancer care services, Affidea is uniquely positioned to help realise the potential of AI and big data in the benefit of patients and doctors. We are trusted with important amounts of data – 13 million scans every year in our 246 centres, located in 16 countries across Europe. These rich datasets can help analyse and benchmark, to work out what works best for patients and clinicians.
You might also like: Building a patient-centric culture in a multinational healthcare provider
“We are developing skills and processes to ensure that AI does what is promised, that the blueprint is in place in terms of clinical and legislative governance and safety, being the ultimate validator.”
Milan Glavaski was invited to take part in a panel discussion at the Private Health Forum 2018, with the conversation focusing on the digitisation of healthcare services using the Cloud, AI and the internet of things.
To find out more about Affidea, click here.
